MyFinsight
Home
Blog
About
Effect of exchange rate
changes on cash, cash...
$22K
(344.44%↑ Y/Y)
Net increase
(decrease) in cash, cash...
-$37,789K
(-71.53%↓ Y/Y)
Canceled cashflow
$22K
Proceeds from maturities
of marketable...
$12,000K
(-63.53%↓ Y/Y)
Stock-based compensation
expense
$2,703K
(-28.09%↓ Y/Y)
Accounts payable
$2,105K
Depreciation expense
$365K
(-85.11%↓ Y/Y)
Non-cash lease expense
$242K
(-25.77%↓ Y/Y)
Net amortization of
premiums and discounts on...
-$1K
Net cash (used in)
provided by investing...
-$17,901K
(-183.33%↓ Y/Y)
Net cash used in
operating activities
-$16,993K
(61.10%↑ Y/Y)
Net cash provided by
financing activities
-$2,917K
(-1748.02%↓ Y/Y)
Canceled cashflow
$12,000K
Canceled cashflow
$5,416K
Purchases of marketable
securities
$29,864K
(167.57%↑ Y/Y)
Net loss
-$18,916K
(61.52%↑ Y/Y)
Proceeds from the
issuance of common stock...
-$2,896K
Proceeds from the
issuance of common stock...
-$21K
Purchases of property and
equipment
$37K
(-85.71%↓ Y/Y)
Accrued expenses and
other current...
-$2,318K
Operating lease
liabilities
-$672K
Prepaid expenses and
other current assets
$399K
Other non-current
assets
$104K
Back
Back
Cash Flow
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)
source: myfinsight.com